You have no items in your shopping cart.
Recovery Protocol
Recovery Protocol™
Vascular Signalling. Cellular Migration. Matrix Remodelling.
BPC-157 · TB-500 · GHK-Cu
The Recovery Protocol™ is a research framework built around three peptide compounds: BPC-157, TB-500, and GHK-Cu. Each compound addresses distinct biological pathways associated with tissue repair, vascular function, and extracellular matrix organisation. Supplied strictly for in-vitro laboratory investigation.
Designed Around Repair Biology
This protocol is structured around three fundamental axes of repair research: endothelial signalling pathways that govern vascular response, cellular migration mechanisms that direct tissue reorganisation, and extracellular matrix dynamics that determine structural integrity.
BPC-157
Endothelial Signalling Research
BPC-157 is studied for its influence on angiogenic pathways and endothelial cell behaviour. Research models suggest involvement in VEGF-mediated signalling and nitric oxide regulation within vascular tissue. In vitro studies demonstrated increased endothelial cell migration and tube formation, with activation of VEGFR2 → Akt → eNOS signalling pathways.
Majority of findings from rodent injury models and cellular assays.
TB-500 (Thymosin β4)
Cytoskeletal & Migration Research
Thymosin β4 has been extensively investigated for its role in cytoskeletal regulation and cellular migration. Research demonstrated it acts as a G-actin sequestration molecule, influencing cytoskeletal reorganisation and facilitating cellular movement. Studies reported accelerated wound closure rates in rodent dermal injury models.
Strong mechanistic evidence within dermal and tissue migration models.
GHK-Cu
Extracellular Matrix & Collagen Research
GHK-Cu is a naturally occurring copper-binding tripeptide with a long research history in tissue remodelling biology. Research demonstrated significantly increased collagen synthesis in cultured human fibroblasts and may influence fibroblast activity, glycosaminoglycan synthesis, and metalloproteinase expression involved in matrix turnover.
Evidence is strongest in fibroblast and dermatological research environments.
Research Context & Supply Position
Precision in Supply.
Discipline in Research.
The Recovery Protocol™ is presented for scientific context only. Mechanisms described reflect experimental literature and should not be interpreted as clinical claims. Axiom supplies all compounds strictly for in-vitro laboratory research.
View Research CompoundsCompliance Position
Axiom products are not approved medicines and are not intended for human consumption, medical treatment, or diagnostic use.
Not for human consumption
Not for medical use
In-vitro research only
Compliance enforced
Controlled. Considered. Engineered.
